VJHemOnc is committed to improving our service to you

SOHO 2020 | ENESTnd: results from an exploratory biomarker analysis in CML

VJHemOnc is committed to improving our service to you

Jerald P. Radich

Jerald P. Radich, MD, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, elaborates on the exploratory biomarker analysis results from the ENESTnd trial (NCT00471497). In this study, it was determined that gene expression signatures can distinguish deep molecular responses from poor response in chronic myeloid leukemia (CML). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).”

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter